FDA Inspection 855192 — Fresenius Kabi USA LLC

Fresenius Kabi USA LLC — FEI 1450022

The FDA completed an inspection of Fresenius Kabi USA LLC on December 11, 2013 in Melrose Park, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 11, 2013
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Melrose Park, IL (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
117721 CFR 211.63Equipment Design, Size and Location
145121 CFR 211.113(b)Procedures for sterile drug products